Dimensional Fund Advisors LP increased its holdings in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 3.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 634,430 shares of the real estate investment trust's stock after buying an additional 20,631 shares during the period. Dimensional Fund Advisors LP owned about 1.40% of National Health Investors worth $43,966,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in NHI. Norges Bank bought a new position in National Health Investors during the 4th quarter worth $42,322,000. Marshall Wace LLP boosted its holdings in National Health Investors by 161.6% in the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock valued at $38,225,000 after acquiring an additional 340,712 shares during the last quarter. Centersquare Investment Management LLC increased its position in National Health Investors by 35.9% during the 4th quarter. Centersquare Investment Management LLC now owns 394,433 shares of the real estate investment trust's stock valued at $27,334,000 after purchasing an additional 104,186 shares during the period. Vanguard Group Inc. raised its holdings in National Health Investors by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 6,423,210 shares of the real estate investment trust's stock worth $445,128,000 after purchasing an additional 102,012 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of National Health Investors by 5.3% in the 4th quarter. Principal Financial Group Inc. now owns 1,648,499 shares of the real estate investment trust's stock worth $114,242,000 after purchasing an additional 82,825 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Price Performance
Shares of National Health Investors stock traded up $1.12 during trading on Friday, hitting $76.99. The stock had a trading volume of 34,635 shares, compared to its average volume of 227,697. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of 26.46, a P/E/G ratio of 4.42 and a beta of 0.78. National Health Investors, Inc. has a 12 month low of $63.91 and a 12 month high of $86.13. The business's 50-day moving average is $74.03 and its 200 day moving average is $72.78. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92.
National Health Investors (NYSE:NHI - Get Free Report) last released its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $68.87 million for the quarter, compared to analysts' expectations of $85.13 million. During the same quarter in the prior year, the firm earned $1.10 earnings per share. The firm's revenue was up 9.6% on a year-over-year basis. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 earnings per share for the current year.
National Health Investors Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be issued a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.68%. The ex-dividend date of this dividend is Monday, June 30th. National Health Investors's dividend payout ratio (DPR) is currently 114.29%.
Analyst Upgrades and Downgrades
Several research firms recently commented on NHI. Truist Financial raised their target price on National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a research note on Wednesday, March 19th. Wedbush reissued an "outperform" rating and issued a $88.00 price target on shares of National Health Investors in a research report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat.com, National Health Investors has an average rating of "Hold" and a consensus price target of $85.50.
Get Our Latest Stock Report on NHI
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading

Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.